[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356322-105":59,"doc-detail-356322-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prdm16-regulates-prostate-cancer-cell-dormancy-and-prevents-bone-metastatic-outgrowth","PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic Outgrowth","","Understanding dormancy in prostate cancer is challenging because of model availability. Using murine and human prostate cancer cell lines, the study generates a stress-induced in vitro dormancy model and shows the dormant phenotype persists after intrailiac artery delivery into the bone marrow microenvironment. RNA sequencing identifies PRDM16 as commonly upregulated in dormant cells, and patient-derived disseminated tumor cells in bone marrow are largely PRDM16-positive. Genetic ablation and ectopic expression support PRDM16’s role in maintaining dormancy. PRDM16 negatively correlates with recurrence and E2F cell-cycle programs, and chromatin immunoprecipitation–qPCR shows PRDM16 binds upstream of RB1, linking dormancy control to metabolic and cell-cycle regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prdm16-regulates-prostate-cancer-cell-dormancy-and-prevents-bone-metastatic-outgrowth/356322/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prdm16-regulates-prostate-cancer-cell-dormancy-and-prevents-bone-metastatic-outgrowth/356322.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does PRDM16 play in prostate cancer dormancy?","Question",{"text":112,"@type":113},"PRDM16 is upregulated in dormant prostate cancer cells and supports maintenance of dormancy in vitro and in vivo. It negatively correlates with disease recurrence and the E2F cell-cycle program in patient-derived disseminated tumor cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the dormancy model generated and validated in this study?",{"text":117,"@type":113},"The study uses murine and human prostate cancer cell lines to create a stress-induced in vitro dormancy model. The phenotype is sustained after intrailiac artery delivery into the bone marrow microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"Through which molecular mechanism does PRDM16 influence dormancy?",{"text":121,"@type":113},"Chromatin immunoprecipitation–qPCR shows PRDM16 binds upstream of the RB1 promoter. RB1 is described as a repressor of E2F activity, linking PRDM16 to inhibition of the cell-cycle program.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356322,1790468394,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic Outgrowth  \nMostafa M. Nasr1,2, Bishoy Wadie3, Tao Li1, Jeremy S. Frieling1, Haley du Bois1, Ryan T. Bishop1, Marilena Tauro1, Baasil Malik1, Karl J. Nyman1,2, and Conor C. Lynch1  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Understanding dormancy in prostate cancer is challenging because of model availability. In this study, using murine and human prostate cancer cell lines, we generated a stress-induced model of dormancy in vitro and demonstrated that the phenotype could be sustained upon intrailiac artery delivery into the bone marrow microenvironment. RNA sequencing analysis revealed that the transcription factor positive regulatory domain–containing 16 (PRDM16) was commonly upregulated in dormant prostate cancer cells compared with controls. Furthermore, bone marrow–disseminated prostate cancer cells from primary orthotopic tumors were largely positive for PRDM16. Genetic ablation and forced ectopic expression supported a role for PRDM16 in maintaining prostate cancer dormancy in vitro and in vivo. Clinically, PRDM16 negatively correlated with disease recurrence and with the E2F cell-cycle program in disseminated tumor cells derived from the bone marrow of patients with prostate cancer. Gene enrichment and characterization studies implicated PRDM16 as a regulator of metabolic and cell-cycle pathways. Chromatin immunoprecipitation–qPCR further revealed that PRDM16 binds upstream of the promoter of RB1, a potent repressor of E2F activity. Overall, this study developed a straightforward method for inducing cancer cell dormancy and applied this approach to find that PRDM16 governs an intrinsic dormancy program in prostate cancer.\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Significance: PRDM16 initiates a dormancy program in prostate cancer cells that is sustained in the bone marrow microenvironment, highlighting PRDM16 as a potential biomarker for relapse and target for eliminating dormant cancer cells.\u003Cbr>\u003Cbr>Created in BioRender. Nasr, M. (2025) [https://BioRender.com/5x7cdrj](https://BioRender.com/5x7cdrj) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nPrevious studies have demonstrated that men with primary prostate cancer can have evidence of disseminated tumor cells (DTC) in their bone marrow even at early stages of the disease (1–3) . DTCs can lay in a dormant state for weeks to years but, for reasons that are only beginning to be uncovered, can reawaken to form active and painful bone lesions that are incurable (4) . Clearly, understanding the mechanisms used by cancer cells to enter a dormant state could yield potential therapies that lead to their elimination, hence the prevention of future metastatic relapse. In  \n1Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 2The Cancer Biology Ph. D. ","cbCaisvqHixQDyLf","https://ap.wps.com/l/cbCaisvqHixQDyLf","pdf",29307065,18,"English","# Introduction\n## Disseminated tumor cell dormancy and reactivation\n## Dormancy definition and host microenvironment cues\n## Cell-intrinsic dormancy mechanisms\n## PRDM16 identification and regulatory pathway","[{\"question\":\"What role does PRDM16 play in prostate cancer dormancy?\",\"answer\":\"PRDM16 is upregulated in dormant prostate cancer cells and supports maintenance of dormancy in vitro and in vivo. It negatively correlates with disease recurrence and the E2F cell-cycle program in patient-derived disseminated tumor cells.\"},{\"question\":\"How was the dormancy model generated and validated in this study?\",\"answer\":\"The study uses murine and human prostate cancer cell lines to create a stress-induced in vitro dormancy model. The phenotype is sustained after intrailiac artery delivery into the bone marrow microenvironment.\"},{\"question\":\"Through which molecular mechanism does PRDM16 influence dormancy?\",\"answer\":\"Chromatin immunoprecipitation–qPCR shows PRDM16 binds upstream of the RB1 promoter. RB1 is described as a repressor of E2F activity, linking PRDM16 to inhibition of the cell-cycle program.\"}]","PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic Outgrowth | PDF",1790124724,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c138b874f6700c5084bcf4572a2159d3.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d85225f48d57dc8ca415108cc07321d.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fabcd036af227eb4d5c2d7385b56490.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f64422a973609c901f8cf97563093f6.webp",980,1311]